Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)

We report a case of refractory idiopathic childhood pyoderma gangrenosum in a young boy who had suffered from this disease since 3 years of age. He had unfavorable responses and intermittent relapses under different combinations of cytotoxic and steroid therapies. Although there was not much informa...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehzadeh, Farhad, Mohammadikebar, Yusef, Enteshary, Afsaneh, Ghanbarpour, Omid, Mirzarahimi, Mehrdad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554516/
https://www.ncbi.nlm.nih.gov/pubmed/31239637
http://dx.doi.org/10.2147/BTT.S203753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554516/
https://www.ncbi.nlm.nih.gov/pubmed/31239637
http://dx.doi.org/10.2147/BTT.S203753

Ejemplares similares